David S. Joseph
Chairman
- 40+ yrs of experience commercializing medtech/pharma
- Co-founder of 4 companies with successful exits (IPO, M&A)
- Multiple past and present board positions
- Chairman and CEO of Othera Pharmaceuticals (2003‐2010), a specialty pharmaceutical company focused on treatments for ophthalmic diseases
- Co‐founder, President, CEO and Chairman of Orthovita (1999‐2008), an orthobiologics company (IPO in 2006; acquired by Stryker (NYSE:SYK) in 2012 for US$350 million)
- Co‐founder, President, CEO and Chairman of Surgical Laser Technologies (IPO in 1989; acquired by Photo Medix in 1992)
- Co‐founder, President, CEO and Chairman of SITE Microsurgical Systems (acquired by Johnson & Johnson Corporation (NYSE:JNJ) in 1983)
- Prior to entrepreneurial career, over 15 years of executive healthcare management experience
- Past and present board appointments include two successful acquisitions: Animas Corporation, a diabetes insulin pump technology acquired by Johnson & Johnson for approximately US$515 million in 2006; Morphotek, a privately held biotechnology company acquired by Eisai Pharmaceuticals for approximately US$325 million in 2007; and Allevi, a 3D bioprinting company. He received an MBA in Healthcare .Administration degree from Xavier University
- BA in Business Administration from Kings College